Jane Howard

1.6k total citations
44 papers, 1.3k citations indexed

About

Jane Howard is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Jane Howard has authored 44 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 11 papers in Molecular Biology and 11 papers in Cancer Research. Recurrent topics in Jane Howard's work include Neuroscience and Neural Engineering (6 papers), Extracellular vesicles in disease (6 papers) and MicroRNA in disease regulation (5 papers). Jane Howard is often cited by papers focused on Neuroscience and Neural Engineering (6 papers), Extracellular vesicles in disease (6 papers) and MicroRNA in disease regulation (5 papers). Jane Howard collaborates with scholars based in United States, Ireland and Canada. Jane Howard's co-authors include Leslie J. Dorfman, Kevin C. McGill, Clifford A. Hudis, Sujata Patil, Patrick G. Morris, Heather L. McArthur, Amanda McCann, Charles W. Young, Larry Norton and Maura N. Dickler and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and Cancer.

In The Last Decade

Jane Howard

42 papers receiving 1.2k citations

Peers

Jane Howard
Sherise D. Ferguson United States
Mateo Ziu United States
Yoshua Esquenazi United States
Amadé Bregy United States
Sherise D. Ferguson United States
Jane Howard
Citations per year, relative to Jane Howard Jane Howard (= 1×) peers Sherise D. Ferguson

Countries citing papers authored by Jane Howard

Since Specialization
Citations

This map shows the geographic impact of Jane Howard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Howard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Howard more than expected).

Fields of papers citing papers by Jane Howard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Howard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Howard. The network helps show where Jane Howard may publish in the future.

Co-authorship network of co-authors of Jane Howard

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Howard. A scholar is included among the top collaborators of Jane Howard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Howard. Jane Howard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Howard, Jane, Cristina Casalou, Brendan S. Kelly, et al.. (2024). Proteomic and metabolomic profiles of plasma-derived Extracellular Vesicles differentiate melanoma patients from healthy controls. Translational Oncology. 50. 102152–102152. 6 indexed citations
2.
Howard, Jane, John A. Browne, Annette Peters, et al.. (2023). The protein and miRNA profile of plasma extracellular vesicles (EVs) can distinguish feline mammary adenocarcinoma patients from healthy feline controls. Scientific Reports. 13(1). 9178–9178. 3 indexed citations
3.
Smolenski, Albert, et al.. (2021). The role of von Willebrand factor in breast cancer metastasis. Translational Oncology. 14(4). 101033–101033. 21 indexed citations
4.
Llop, Esther, Jane Howard, Stephen F. Madden, et al.. (2021). 5-AZA-dC induces epigenetic changes associated with modified glycosylation of secreted glycoproteins and increased EMT and migration in chemo-sensitive cancer cells. Clinical Epigenetics. 13(1). 34–34. 19 indexed citations
5.
Howard, Jane, et al.. (2021). The potential role of cofilin-1 in promoting triple negative breast cancer (TNBC) metastasis via the extracellular vesicles (EVs). Translational Oncology. 15(1). 101247–101247. 20 indexed citations
6.
Howard, Jane, Cathy Wyse, David J. Argyle, et al.. (2020). Exosomes as Biomarkers of Human and Feline Mammary Tumours; A Comparative Medicine Approach to Unravelling the Aggressiveness of TNBC. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1874(2). 188431–188431. 19 indexed citations
7.
Wyse, Cathy, Matthew Ho, Jane Howard, et al.. (2020). Exosomes in triple negative breast cancer: Garbage disposals or Trojan horses?. Cancer Letters. 473. 90–97. 52 indexed citations
8.
Conlon, Niamh, Jane Howard, Jeffrey Catalano, et al.. (2016). Breast Carcinoma in Young Women: No Evidence of Increasing Rates of Metastatic Breast Carcinoma in a Single Tertiary Center Review. The Breast Journal. 22(3). 287–292. 6 indexed citations
9.
Conlon, Niamh, Dara S. Ross, Jane Howard, et al.. (2015). Is There a Role for Oncotype Dx Testing in Invasive Lobular Carcinoma?. The Breast Journal. 21(5). 514–519. 32 indexed citations
10.
Morris, Patrick G., Conleth G. Murphy, Divya Mallam, et al.. (2012). Limited Overall Survival in Patients with Brain Metastases from Triple Negative Breast Cancer. The Breast Journal. 18(4). 345–350. 32 indexed citations
11.
Morris, Patrick G., Gary A. Ulaner, Anne Eaton, et al.. (2012). Standardized uptake value by positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer. Cancer. 118(22). 5454–5462. 47 indexed citations
12.
Inglis, James, et al.. (2011). Decreased motor unit discharge rate in the potentiated human tibialis anterior muscle. Acta Physiologica. 201(4). 483–492. 34 indexed citations
13.
Murphy, Conleth G., Divya Mallam, Sujata Patil, et al.. (2011). Current or recent pregnancy is associated with adverse pathologic features but not impaired survival in early breast cancer. Cancer. 118(13). 3254–3259. 75 indexed citations
14.
Martin, Robert C.G., Jane Howard, K. Thomas Robbins, et al.. (2010). Toxicity of Irinotecan-Eluting Beads in the Treatment of Hepatic Malignancies: Results of a Multi-Institutional Registry. CardioVascular and Interventional Radiology. 33(5). 960–966. 64 indexed citations
15.
Howard, Jane, et al.. (2009). Effectiveness of an HbA1c tracking tool on primary care managementof diabetes mellitus: glycaemic control, clinical practice andusability. Journal of Innovation in Health Informatics. 17(1). 41–46. 8 indexed citations
16.
Hurria, Arti, A. Hurria, Katherine S. Panageas, et al.. (2005). Effect of Creatinine Clearance on Patterns of Toxicity in Older Patients Receiving Adjuvant Chemotherapy for Breast Cancer. Drugs & Aging. 22(9). 785–791. 27 indexed citations
17.
Hurria, Arti, Katherine S. Panageas, Carol Pearce, et al.. (2005). Patterns of toxicity in older patients with breast cancer receiving adjuvant chemotherapy. Breast Cancer Research and Treatment. 92(2). 151–156. 35 indexed citations
18.
Hurria, Arti, Katherine S. Panageas, Ann A. Jakubowski, et al.. (2005). Change in Cycle 1 to Cycle 2 Haematological Counts Predicts Toxicity in Older Patients with Breast Cancer Receiving Adjuvant Chemotherapy. Drugs & Aging. 22(8). 709–715. 11 indexed citations
19.
Dorfman, Leslie J., Jane Howard, & Kevin C. McGill. (1990). Triphasic behavioral response of motor units to submaximal fatiguing exercise. Muscle & Nerve. 13(7). 621–628. 63 indexed citations
20.
Dorfman, Leslie J., Jane Howard, & Kevin C. McGill. (1988). Influence of contractile force on properties of motor unit action potentials: ADEMG analysis. Journal of the Neurological Sciences. 86(2-3). 125–136. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026